Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2014 Jan 2

PMID 24381574

Citations 15

Authors

Lisa K Denzin

Affiliations

Soon will be listed here.

Abstract

Major histocompatibility class II (MHCII) molecules are loaded with peptides derived from foreign and self-proteins within the endosomes and lysosomes of antigen presenting cells (APCs). This process is mediated by interaction of MHCII with the conserved, non-polymorphic MHCII like molecule HLA-DM (DM). DM activity is directly opposed by HLA-DO (DO), another conserved, non-polymorphic MHCII like molecule. DO is an MHCII substrate mimic. Binding of DO to DM prevents MHCII from binding to DM, thereby inhibiting peptide loading. Inhibition of DM function enables low stability MHC complexes to survive and populate the surface of APCs. As a consequence, DO promotes the display of a broader pool of low abundance self-peptides. Broadening the peptide repertoire theoretically reduces the likelihood of inadvertently acquiring a density of self-ligands that is sufficient to activate self-reactive T cells. One function of DO, therefore, is to promote T cell tolerance by shaping the visible image of self. Recent data also shows that DO influences the adaptive immune response by controlling B cell entry into the germinal center reaction. This review explores the data supporting these concepts.

Citing Articles

H2-O deficiency promotes regulatory T cell differentiation and CD4 T cell hyperactivity.

Welsh R, Song N, Park C, Peske J, Sadegh-Nasseri S Front Immunol. 2024; 14:1304798.

PMID: 38250071 PMC: 10796743. DOI: 10.3389/fimmu.2023.1304798.

Role of B cells as antigen presenting cells.

Rastogi I, Jeon D, Moseman J, Muralidhar A, Potluri H, McNeel D Front Immunol. 2022; 13:954936.

PMID: 36159874 PMC: 9493130. DOI: 10.3389/fimmu.2022.954936.

Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome.

Santambrogio L Front Immunol. 2022; 13:878271.

PMID: 35651601 PMC: 9148998. DOI: 10.3389/fimmu.2022.878271.

Partnering for the major histocompatibility complex class II and antigenic determinant requires flexibility and chaperons.

Sadegh-Nasseri S Curr Opin Immunol. 2021; 70:112-121.

PMID: 34146954 PMC: 8373735. DOI: 10.1016/j.coi.2021.05.005.

How a Proposed Hypothesis during My PhD Training Shaped My Career.

Sadegh-Nasseri S Crit Rev Immunol. 2021; 40(5):449-464.

PMID: 33463956 PMC: 11014643. DOI: 10.1615/CritRevImmunol.2020035324.

References

Painter C, Stern L . Conformational variation in structures of classical and non-classical MHCII proteins and functional implications. Immunol Rev. 2012; 250(1):144-57. PMC: 3471379. DOI: 10.1111/imr.12003. View

Draghi N, Denzin L . H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers. Proc Natl Acad Sci U S A. 2010; 107(38):16607-12. PMC: 2944729. DOI: 10.1073/pnas.1004664107. View

Denzin L, Fallas J, Prendes M, Yi W . Right place, right time, right peptide: DO keeps DM focused. Immunol Rev. 2005; 207:279-92. DOI: 10.1111/j.0105-2896.2005.00302.x. View

Glazier K, Hake S, Tobin H, Chadburn A, Schattner E, Denzin L . Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. J Exp Med. 2002; 195(8):1063-9. PMC: 2193692. DOI: 10.1084/jem.20012059. View

Chen X, Laur O, Kambayashi T, Li S, Bray R, Weber D . Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J Exp Med. 2002; 195(8):1053-62. PMC: 2193689. DOI: 10.1084/jem.20012066. View

Mathis D, Benoist C . Back to central tolerance. Immunity. 2004; 20(5):509-16. DOI: 10.1016/s1074-7613(04)00111-6. View

Karlsson L . DM and DO shape the repertoire of peptide-MHC-class-II complexes. Curr Opin Immunol. 2005; 17(1):65-70. DOI: 10.1016/j.coi.2004.11.003. View

Blum J, Wearsch P, Cresswell P . Pathways of antigen processing. Annu Rev Immunol. 2013; 31:443-73. PMC: 4026165. DOI: 10.1146/annurev-immunol-032712-095910. View

Yoon T, Macmillan H, Mortimer S, Jiang W, Rinderknecht C, Stern L . Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis. Proc Natl Acad Sci U S A. 2012; 109(28):11276-81. PMC: 3396517. DOI: 10.1073/pnas.1113966109. View

10.

Guce A, Mortimer S, Yoon T, Painter C, Jiang W, Mellins E . HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism. Nat Struct Mol Biol. 2012; 20(1):90-8. PMC: 3537886. DOI: 10.1038/nsmb.2460. View

11.

Pos W, Sethi D, Wucherpfennig K . Mechanisms of peptide repertoire selection by HLA-DM. Trends Immunol. 2013; 34(10):495-501. PMC: 3796002. DOI: 10.1016/j.it.2013.06.002. View

12.

Perraudeau M, Taylor P, Stauss H, Lindstedt R, Bygrave A, Pappin D . Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice. Eur J Immunol. 2000; 30(10):2871-80. DOI: 10.1002/1521-4141(200010)30:10<2871::AID-IMMU2871>3.0.CO;2-B. View

13.

Anderson M, Bluestone J . The NOD mouse: a model of immune dysregulation. Annu Rev Immunol. 2005; 23:447-85. DOI: 10.1146/annurev.immunol.23.021704.115643. View

14.

Ghosh P, Amaya M, Mellins E, Wiley D . The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature. 1995; 378(6556):457-62. DOI: 10.1038/378457a0. View

15.

Yi W, Seth N, Martillotti T, Wucherpfennig K, SantAngelo D, Denzin L . Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence. J Clin Invest. 2010; 120(4):1324-36. PMC: 2846047. DOI: 10.1172/JCI40220. View

16.

Jensen P, Weber D, Thayer W, Chen X, Dao C . HLA-DM and the MHC class II antigen presentation pathway. Immunol Res. 2000; 20(3):195-205. DOI: 10.1007/BF02790403. View

17.

Chen X, Reed-Loisel L, Karlsson L, Jensen P . H2-O expression in primary dendritic cells. J Immunol. 2006; 176(6):3548-56. DOI: 10.4049/jimmunol.176.6.3548. View

18.

McHeyzer-Williams L, Pelletier N, Mark L, Fazilleau N, McHeyzer-Williams M . Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol. 2009; 21(3):266-73. PMC: 2731669. DOI: 10.1016/j.coi.2009.05.010. View

19.

Riberdy J, Newcomb J, Surman M, Barbosa J, Cresswell P . HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature. 1992; 360(6403):474-7. DOI: 10.1038/360474a0. View

20.

Gu Y, Jensen P, Chen X . Immunodeficiency and autoimmunity in H2-O-deficient mice. J Immunol. 2012; 190(1):126-37. DOI: 10.4049/jimmunol.1200993. View